Future therapies for pre-eclampsia: beyond treading water

Christine Fenton, Sebastian Rupert Hobson, Euan Morrison Wallace, Rebecca Seok Wai Lim

Research output: Contribution to journalArticleResearchpeer-review

15 Citations (Scopus)

Abstract

Pre-eclampsia remains a major burden of disease, accounting for approximately 50,000-70,000 maternal deaths each year worldwide. Frustratingly, the management of pre-eclampsia has remained essentially unchanged for much of the last century and focussed primarily on maternal blood pressure control to allow fetal maturation. Recent advances in the understanding of the pathogenesis of pre-eclampsia and the elucidation of distinct underlying mechanisms offer the genuine prospect of new and effective therapies that may transform outcomes for millions of women and their babies
Original languageEnglish
Pages (from-to)3 - 8
Number of pages6
JournalAustralian and New Zealand Journal of Obstetrics and Gynaecology
Volume54
Issue number1
DOIs
Publication statusPublished - 2014

Cite this

@article{263bb82ac4874ad9aba16c07dd615abe,
title = "Future therapies for pre-eclampsia: beyond treading water",
abstract = "Pre-eclampsia remains a major burden of disease, accounting for approximately 50,000-70,000 maternal deaths each year worldwide. Frustratingly, the management of pre-eclampsia has remained essentially unchanged for much of the last century and focussed primarily on maternal blood pressure control to allow fetal maturation. Recent advances in the understanding of the pathogenesis of pre-eclampsia and the elucidation of distinct underlying mechanisms offer the genuine prospect of new and effective therapies that may transform outcomes for millions of women and their babies",
author = "Christine Fenton and Hobson, {Sebastian Rupert} and Wallace, {Euan Morrison} and Lim, {Rebecca Seok Wai}",
year = "2014",
doi = "10.1111/ajo.12134",
language = "English",
volume = "54",
pages = "3 -- 8",
journal = "Australian and New Zealand Journal of Obstetrics and Gynaecology",
issn = "0004-8666",
publisher = "Wiley-Blackwell",
number = "1",

}

Future therapies for pre-eclampsia: beyond treading water. / Fenton, Christine; Hobson, Sebastian Rupert; Wallace, Euan Morrison; Lim, Rebecca Seok Wai.

In: Australian and New Zealand Journal of Obstetrics and Gynaecology, Vol. 54, No. 1, 2014, p. 3 - 8.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Future therapies for pre-eclampsia: beyond treading water

AU - Fenton, Christine

AU - Hobson, Sebastian Rupert

AU - Wallace, Euan Morrison

AU - Lim, Rebecca Seok Wai

PY - 2014

Y1 - 2014

N2 - Pre-eclampsia remains a major burden of disease, accounting for approximately 50,000-70,000 maternal deaths each year worldwide. Frustratingly, the management of pre-eclampsia has remained essentially unchanged for much of the last century and focussed primarily on maternal blood pressure control to allow fetal maturation. Recent advances in the understanding of the pathogenesis of pre-eclampsia and the elucidation of distinct underlying mechanisms offer the genuine prospect of new and effective therapies that may transform outcomes for millions of women and their babies

AB - Pre-eclampsia remains a major burden of disease, accounting for approximately 50,000-70,000 maternal deaths each year worldwide. Frustratingly, the management of pre-eclampsia has remained essentially unchanged for much of the last century and focussed primarily on maternal blood pressure control to allow fetal maturation. Recent advances in the understanding of the pathogenesis of pre-eclampsia and the elucidation of distinct underlying mechanisms offer the genuine prospect of new and effective therapies that may transform outcomes for millions of women and their babies

UR - http://onlinelibrary.wiley.com/doi/10.1111/ajo.12134/pdf

U2 - 10.1111/ajo.12134

DO - 10.1111/ajo.12134

M3 - Article

VL - 54

SP - 3

EP - 8

JO - Australian and New Zealand Journal of Obstetrics and Gynaecology

JF - Australian and New Zealand Journal of Obstetrics and Gynaecology

SN - 0004-8666

IS - 1

ER -